Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study. [electronic resource]
Producer: 20050217Description: 5418-24 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Small Cell -- drug therapy
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Esophagitis -- chemically induced
- Etoposide -- administration & dosage
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neutropenia -- chemically induced
- Radiation-Sensitizing Agents -- toxicity
- Radiotherapy Dosage
- Tirapazamine
- Triazines -- toxicity
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.